N,N'-Bis(2,6-diisopropylphenyl)-3,4,9,10-perylenetetracarboxylic Diimide>98.0%(N)5g

2-(2-bromophenyl)-2'-cyanoacetophenone, 97.0%, 1g

6-OXO-5,6-DIHYDRO[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBALDEHYDE, 95%, 1g

5,8,11,14-Tetraoxa-2-azahexadecanoic acid, 16-hydroxy-, 1,1-dimethylethyl ester, 95%, 1g

8-bOc-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-8-aza-bicyclo[3.2.1]octane, 98%, 10g

3-Cyano-5-fluorobenzene-1-sulfonyl chloride, 97%, 250mg

2,3-DIOXOINDOLINE-5-CARBOXAMIDE, 95.0%, 25mg

monovanadato trisódico, mínimo 99 %, puro, 10 g, envase de plástico.

N,N-Diethylacetamide, 95.0%, 100g

(3-((tert-Butoxycarbonyl)amino)-4-methylphenyl)boronic acid, 97%, 1g

(4S,5R)-4,5-Diphenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole, 95.0%, 1g

L-Cystine dihydrochloride, 98.0%, 5g

1-Boc-5-methyl-3-piperidinone, 97%, 100mg